Immune Aging: When the Body's First Line of Defense Begins to Carry the Burden of Time

New research reveals divergent immune-aging trajectories. Together with earlier findings on reversible immunosenescence, it offers new insights into how cumulative exposure, bioenergetic strain, and incomplete recovery may drive biological aging.

Aging is commonly described as the gradual accumulation of cellular damage. Mitochondria become dysfunctional, DNA damage accumulates, inflammation persists, and senescent cells increasingly interfere with tissue function.

But an important question remains:

What governs the progression from repeated physiological challenges to persistent dysfunction and, eventually, irreversible deterioration?

The immune system may provide a particularly revealing window into this process.

As the body's frontline system for responding to environmental and internal threats, immune cells continuously confront infections, toxins, tissue injury, metabolic disturbances, and inflammatory signals. They must recognize these challenges, mobilize resources, mount appropriate responses, and ultimately restore homeostasis.

These activities require substantial bioenergetic investment.

A major new study published in Immunity by Terekhova and colleagues (2026) reveals that immune aging does not follow one uniform trajectory. Instead, older individuals exhibit distinct patterns of immune-cell remodeling associated with markedly different health outcomes.

When considered alongside earlier research on immune senescence, mitochondrial dysfunction, and the capacity to reverse some senescence-like states, these findings offer support for a broader interpretation of aging:

the cumulative consequences of adaptation under increasingly constrained bioenergetic conditions.

Immune Aging Is More Than Getting Older

Terekhova and colleagues assembled one of the largest single-cell analyses of human immune aging to date, integrating eight cohorts involving 2,609 individuals and approximately 12.4 million immune cells.

They identified 59 immune-cell populations and examined how these populations changed with age, biological sex, ancestry, chronic infections, and health status.

Several familiar patterns emerged.

With advancing age, the thymus progressively produces fewer new T cells. Consequently, recent thymic emigrants and naive CD8+ T cells decline, while memory and differentiated T-cell populations become more prominent.

These changes reflect the accumulated history of immune-system development and repeated encounters with antigens.

However, chronological age explained only part of the variation.

Among older individuals, the researchers identified two particularly interesting patterns involving CD8+ effector memory T cells.

One was enriched in cells expressing granzyme K (GZMK), while the other was enriched in cells expressing granzyme B (GZMB).

The ratio between these populations distinguished different health-associated immune trajectories.

A relatively higher GZMK+/GZMB+ ratio was associated with healthier aging, whereas a lower ratio was associated with chronic immune perturbation, inflammatory conditions, and poorer health outcomes.

Importantly, the ratio was influenced by chronic cytomegalovirus (CMV) exposure and disease-associated immune dysregulation rather than simply increasing or decreasing with chronological age.

This suggests that immune aging carries information about an individual's history of physiological challenges, not merely the number of years lived.

Two Immune Trajectories: Different Stages of Adaptation?

Both GZMK+ and GZMB+ memory T-cell populations tend to increase with age. However, they appear to represent different immune configurations.

In human peripheral blood, GZMK+ effector memory cells generally occupy an intermediate differentiation state, while GZMB+ cells are more closely associated with terminal differentiation and cytotoxic activity.

The researchers also connected greater GZMB+ abundance with systemic inflammation, chronic diseases, and increased mortality risk.

Using plasma proteomic signatures, they estimated GZMB+ immune-cell abundance in more than 48,000 UK Biobank participants. Higher predicted levels were associated with poorer health, elevated inflammatory markers, and increased risk of several cardiovascular, metabolic, and immune-related conditions.

These observations raise an important question.

Could the two immune configurations reflect different positions along a continuum of physiological compensation and decompensation?

From our bioenergetic impedance perspective, one possibility is that relatively preserved immune-memory configurations represent ongoing adaptation in which the organism can still maintain functional responses, even at increasing energetic cost.

With persistent exposure and unresolved physiological demands, immune-cell populations may progressively reorganize toward more terminally differentiated states.

Such reorganization might initially preserve essential defenses while reducing adaptability, increasing inflammatory persistence, and placing greater demands on the remaining recovery machinery.

Eventually, the organism may maintain substantial immune activation without efficiently restoring homeostasis.

This interpretation does not mean that GZMK+ cells are inherently compensatory or that GZMB+ cells are intrinsically dysfunctional. GZMB+ cells remain important functional cytotoxic effectors, and the study did not directly measure their bioenergetic reserve.

Rather, the findings suggest that the balance between immune-cell populations may reveal how adaptation has been reorganized under different histories of cumulative demand.

Why the Immune System May Show Aging Earlier Than Other Tissues

The immune system occupies a distinctive position in the aging process.

Unlike many structural tissues, immune cells are constantly mobilized to respond to external and internal disturbances.

An infection triggers immune activation.

Tissue injury releases danger-associated molecular patterns (DAMPs).

Metabolic dysfunction alters inflammatory signaling.

Environmental exposures can impose oxidative and cellular stress.

Even after the immediate challenge disappears, the immune system must complete the work of resolution, repair, and restoration.

Each response requires energy, nutrients, biosynthetic resources, and coordinated cellular regulation.

This creates the possibility that immune cells accumulate substantial adaptive strain before overt functional deterioration becomes visible in other tissues.

Importantly, experimental evidence suggests that immune aging can do more than accompany systemic aging.

A 2021 study published in Nature, “An aged immune system drives senescence and ageing of solid organs,” demonstrated that inducing premature immune aging in mice promoted senescence and damage in nonimmune tissues. Transferring aged immune cells could also induce senescence-associated changes, while younger immune cells attenuated some of these effects.

These findings provide evidence that immune dysfunction can contribute causally to wider tissue aging, at least in experimental animals.

They do not establish that immunosenescence universally precedes other cellular senescence in humans. Nevertheless, they support the possibility that immune aging is not merely a downstream consequence of tissue deterioration.

It may participate in initiating and propagating the process.

From a bioenergetic perspective, immune cells could therefore act as both early indicators of cumulative physiological strain and amplifiers of unresolved adaptation throughout the body.

Immunosenescence May Not Always Be Irreversible

Another important development challenges the conventional interpretation of cellular senescence as an irreversible endpoint.

In 2017, Lanna and colleagues demonstrated that some senescent-like T cells retain substantial functional plasticity.

Their study, published in Nature Immunology, identified a sestrin-dependent signaling complex involving ERK, JNK, and p38 MAP kinases that inhibits immune function during aging.

Disrupting this complex restored several functional responses in aged or stressed T cells. In experimental animals, targeting this signaling mechanism also improved responses to vaccination.

These findings suggest that some features traditionally associated with T-cell senescence are maintained through active regulatory mechanisms rather than being entirely irreversible.

This distinction is important.

Cellular senescence is not a single uniform biological condition. Some states involve deeply established proliferative arrest and persistent molecular damage, while others display senescence-like characteristics that remain susceptible to functional reprogramming.

Immune cells may therefore enter states of reduced proliferation, altered signaling, or constrained responsiveness without necessarily losing all capacity for recovery.

Within our framework, such states could represent adaptive responses to prolonged physiological demand.

As long as sufficient bioenergetic and regulatory capacity remains available, some aspects of immune dysfunction may be reversible.

However, continued stress, metabolic impairment, and incomplete resolution could progressively stabilize these altered states, making recovery more difficult.

The essential distinction may not simply be whether a cell displays senescence-associated markers, but whether it retains the capacity to recover its function.

Mitochondrial Dysfunction Connects Immune Senescence to Failed Regulation

Further evidence comes from Soto-Heredero and colleagues, whose 2025 study in Nature Aging examined aging-associated regulatory T cells.

Regulatory T cells help restrain excessive immune activation and maintain immune tolerance.

Their work identified a population of KLRG1-expressing regulatory T cells that accumulates with age and exhibits mitochondrial alterations, DNA damage, and senescence-associated features.

Importantly, these cells also showed reduced suppressive activity and a more pro-inflammatory phenotype.

This finding introduces a critical distinction between generating an immune response and successfully resolving it.

Immune activation alone is not sufficient for maintaining health.

The organism must also sustain the regulatory processes necessary to terminate inflammation, clear damaged components, and restore tissue homeostasis.

If bioenergetic constraints compromise these counter-regulatory functions, the immune system may remain activated even after the original challenge has diminished.

This can create a self-reinforcing cycle: persistent inflammation promotes further tissue stress, additional danger signaling, and renewed immune activation.

The result may be increasing physiological expenditure without successful resolution.

From Exposure to Bioenergetic Impedance and Recovery Backlog

These findings can be connected through our previously published bioenergetic impedance perspective.

Bioenergetic impedance describes constraints on the delivery, processing, utilization, and recovery of energetic resources relative to physiological demand.

An organism does not become impaired simply because energy substrates or oxygen are unavailable. Dysfunction may also emerge when resources cannot be delivered efficiently, processed appropriately, allocated to competing demands, or used to complete recovery.

Repeated challenges require continual prioritization.

Through allostatic triage, immediate survival and essential functions may receive priority over longer-term maintenance, regeneration, and repair.

Compensatory metabolic reorganization can preserve short-term function, but it may carry additional physiological costs.

When incoming challenges exceed the organism's effective resolution capacity, unfinished recovery demands can accumulate.

We describe this as a recovery backlog.

The proposed continuum is:

Cumulative exposure → repeated stress adaptation → bioenergetic strain and impedance → incomplete resolution → increasing recovery backlog → compensatory reorganization → persistent dysfunction and decompensation.

In this interpretation, immune memory provides one record of previous encounters and adaptation, while immune-cell differentiation and regulatory capacity may offer additional information about how that history affects present physiological function.

An expanded memory-cell compartment does not necessarily imply impaired health or excessive energetic burden. Adaptive memory is essential for protection.

The concern arises when repeated or persistent immune demands are accompanied by declining regulatory flexibility, metabolic constraints, and incomplete recovery.

Over time, this could contribute to compensatory lock-in: a state in which the organism maintains an altered functional configuration even after the original disturbance has diminished.

Such persistence is closely related to the concept of hysteresis, where biological history influences the system's present state and its response to future challenges.

Aging May Advance Even When Exposure Does Not Increase

One of the most important implications of this framework is that aging does not necessarily require progressively increasing external stress.

Consider two individuals exposed to similar physiological demands.

One has sufficient reserve to mobilize an effective response, resolve the disturbance, and return toward baseline.

The other carries a substantial burden of unresolved adaptation from earlier challenges.

Even if the new exposure is identical, the second individual may require more time and resources to recover.

If recovery remains incomplete, the existing backlog increases.

Over time, the organism can become progressively less capable of responding to challenges that were previously manageable.

This provides a potential explanation for why individuals of similar chronological age exhibit markedly different immune and physiological trajectories.

It may also explain why apparently preserved function can coexist with substantial underlying reserve erosion.

The visible deterioration may occur only when compensatory mechanisms can no longer sustain the demands placed upon them.

In this sense, aging-related disease may sometimes represent the clinical manifestation of a much longer process of constrained adaptation, rather than the beginning of dysfunction itself.

Immunosenescence: Both a Consequence and a Driver of Aging

Immune cells have another responsibility that makes their aging particularly consequential: they participate in the recognition and clearance of damaged and senescent cells.

As immune function deteriorates, the organism may become less effective at removing these cells.

Persistent senescent cells can, in turn, generate inflammatory signals that increase immune activation and impose additional demands on tissue maintenance.

This creates a potentially self-reinforcing process:

Immune dysfunction → impaired clearance and inflammatory resolution → accumulation of tissue damage and senescent cells → increased inflammatory signaling → further immune strain.

The immune system may therefore occupy a critical position between local cellular stress and systemic aging.

Initially, immune remodeling may reflect the organism's attempt to preserve homeostasis.

Later, when regulatory and recovery capacities become constrained, the same system may contribute to the persistence and propagation of dysfunction.

This supports viewing immunosenescence not simply as a hallmark of aging, but as a potentially important participant in the transition from adaptation to systemic deterioration.

What These Studies Establish—and What Remains to Be Tested

Taken together, the studies provide several complementary observations.

Terekhova and colleagues show that immune aging follows heterogeneous trajectories associated with exposure history and future health outcomes.

Lanna and colleagues demonstrate that certain senescence-like immune states retain functional reversibility.

Soto-Heredero and colleagues connect mitochondrial alterations with impaired immune regulation and pro-inflammatory remodeling.

Experimental work on prematurely aged immune systems shows that immune senescence can contribute to the development of senescence in other organs.

These findings are compatible with the bioenergetic impedance and recovery-dynamics framework, but they do not yet establish its proposed causal sequence.

Several questions remain central.

Does increasing bioenergetic impedance precede maladaptive immune differentiation? Does unresolved recovery backlog predict immune dysfunction independently of chronological age and chronic infection?

Can restoring metabolic flexibility and resolution capacity reverse unfavorable immune configurations?

And do changes in immune recovery kinetics precede broader tissue deterioration?

Answering these questions will require longitudinal studies combining immune phenotyping, bioenergetic measurements, standardized physiological challenges, and post-challenge recovery tracking.

Of particular interest would be measuring whether the GZMK+/GZMB+ ratio relates to mitochondrial reserve, regulatory T-cell competence, inflammatory resolution time, and the persistence of residual dysfunction after repeated challenges.

Toward a Governing Framework of Biological Aging

Modern aging science has identified numerous molecular and cellular hallmarks. Each contributes important knowledge about how organisms change with age.

Yet the hallmarks alone do not fully explain why these processes emerge together, why different individuals follow different trajectories, or why some changes remain reversible while others become persistent.

The bioenergetic impedance perspective proposes a unifying physiological explanation.

Aging may reflect the cumulative consequences of repeated adaptation under progressively constrained energetic and recovery conditions.

Initially, biological systems compensate. They reorganize metabolism, alter cellular signaling, redistribute resources, and preserve essential functions.

With repeated challenges and incomplete recovery, these adaptations may become increasingly costly and persistent.

Eventually, the accumulated burden can overwhelm remaining reserve, producing impaired regulation, functional decline, and systemic disease.

The immune system may be particularly informative because it continuously encounters the challenges that drive adaptation, retains memory of previous exposure, and influences the inflammatory environment of other tissues.

The emerging question in aging science is therefore not only how much damage has accumulated, but how much unfinished adaptation remains—and whether the organism still possesses sufficient capacity to recover.

This distinction offers a different way of understanding biological aging: not merely as the passage of time or accumulation of senescent cells, but as a progressive shift from effective adaptation toward persistent compensation and, ultimately, constrained recovery.

The recent immune-aging findings do not prove this governing framework. They do, however, provide important cellular and clinical observations through which its predictions can be investigated.

And they remind us of an essential possibility: some manifestations of biological aging may remain reversible long before they become clinically apparent as irreversible decline.

Selected scientific references

1. Terekhova, M., et al. (2026). Single-cell analyses of global cohorts outline determinants of immune aging and link the ratio of GZMK+ to GZMB+ Tem cells to health trajectories. Immunity. https://doi.org/10.1016/j.immuni.2026.09.012

2. Lanna, A., et al. (2017). A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging. Nature Immunology, 18, 354–363. https://doi.org/10.1038/ni.3665

3. Soto-Heredero, G., et al. (2025). KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging. Nature Aging, 5, 799–815. https://doi.org/10.1038/s43587-025-00855-9

4. Yousefzadeh, M. J., Flores, R. R., Zhu, Y., et al. (2021). An aged immune system drives senescence and ageing of solid organs. Nature, 594, 100–105. https://doi.org/10.1038/s41586-021-03547-7